Superbugs & Superdrugs USA 2018

3rd annual Superbugs & Superdrugs USA is organized by SMi Group Ltd and will be held from Nov 12 - 13, 2018 at Renaissance Woodbridge Hotel, Iselin, New Jersey, United States of America.

The target audience for this medical event is Chief Scientific Officer, Chief operating officer, Chief Medical Officer, Research and Development Manager, Research and Development Director, Research and Development Scientist, Research Assistant, Research Technologist, Professors, Doctors, Research Scientist, PhD student, Research Fellow, Principal Lecturers, Sales Directors, Business Development, Marketing Director, Business Coordinators, Engagement Manager

Course Description:
This year's event is set to address the issue of antibacterial resistance, which is becoming increasingly prevalent in the world of modern medicine. Difficult-to-treat pathogens creating issues within clinical environments need to be addressed with novel treatments and the development of mechanisms which circumvent current therapeutic barriers.

To address the ever-growing need of informative and thought-provoking discussion, Superbugs And Superdrugs USA conference will offer a jam-packed agenda with presentations from key industry leaders and up-and-coming thinkers within the field, as well as the opportunity to network with decision makers from the industry - from research, to commercial providers and regulatory bodies.

Course Highlights:
• Learn about pathogen-focused drug development
• Discover the best methods to overcome bacterial resistance though novel modes of action
• Discuss the state of developments within the anti-fungal space
• Develop an understanding of funding opportunities which support antibacterial research
• Gain insight into new techniques through case-study examples of rapid diagnostic methods currently being used

In addition, two interactive half-day workshops will be running on 14th November:
Workshop A: "Rapid diagnostics for drug resistance: Are we there yet?", led by David Perlin, Executive Director And Professor, Public Health Research Institute, Rutgers University.

Workshop B: "Avoiding the post antibiotic era: the challenges and solutions to successful commercialisation of new antibiotics", hosted by Adam Woodrow, CCO, Parateck, and David Findlay, Managing Director, Morton Findlay and Associates Ltd.

Workshop Fee: $ 499

Additional details will be posted as soon as they are available.